The latest price target for GoHealth (NASDAQ:GOCO) was reported by RBC Capital on March 20, 2024. The analyst firm set a price target for $13.00 expecting GOCO to rise to within 12 months (a possible 31.71% upside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for GoHealth (NASDAQ:GOCO) was provided by RBC Capital, and GoHealth maintained their sector perform rating.

There is no last upgrade for GoHealth

The last downgrade for GoHealth Inc happened on March 3, 2022 when RBC Capital changed their price target from $10 to $2 for GoHealth Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of GoHealth, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for GoHealth was filed on March 20, 2024 so you should expect the next rating to be made available sometime around March 20, 2025.

While ratings are subjective and will change, the latest GoHealth (GOCO) rating was a maintained with a price target of $20.00 to $13.00. The current price GoHealth (GOCO) is trading at is $9.87, which is out of the analyst’s predicted range.